MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-04-0059756
Cisza Pharmaceuticals Private Limited
Cisza Pharmaceuticals Private Limited - pharma in Aurangabad, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹60.58 Lakh
▲ 38% YoY
Net profit · FY 2025
₹67,895
Net margin 1.1%
EBITDA · FY 2025
₹2.57 Lakh
EBITDA margin 4.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Cisza Pharmaceuticals Private Limited
Data last updated:
Cisza Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24297MH2020PTC349749.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rameshwar Uttamrao Mangate and Sandeep Uttamrao Mangate.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gut No. 151/P Plot No. 38 Disha Nisarg, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2025, the company reported a revenue of ₹60.58 Lakh, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹67,895 (net margin 1.1%) and EBITDA of ₹2.57 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 53% over three years.
Cisza Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0059756).
Company details
CIN U24297MH2020PTC349749
Registration Number 349749
Incorporation Date 09 November 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-04-0059756
Recognitions & Rankings of Cisza Pharmaceuticals
Contact details
Cisza Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra.
- Registered AddressGut No. 151/P Plot No. 38 Disha Nisarg, Aurangabad, Maharashtra, India – 431001
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Cisza Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Cisza Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Cisza Pharmaceuticals Private Limited, buy the company report.
Financials of Cisza Pharmaceuticals Private Limited
FY 2025 filings availableCisza Pharmaceuticals Private Limited reported revenue of ₹60.58 Lakh (up 38% YoY) for FY 2025.
Revenue · FY 2025
₹60.58 Lakh ▲ 38%
Net profit · FY 2025
₹67,895 margin 1.1%
EBITDA · FY 2025
₹2.57 Lakh margin 4.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 53%
EBITDA CAGR growth
1 year
▲ 141%
3 years · compounded
▲ 131%
Revenue has grown at a compounded annual rate (CAGR) of 53% over three years, including 38% growth in the latest year. EBITDA rose 141% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹67,895 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cisza Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cisza Pharmaceuticals Private Limited
Cisza Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rameshwar Uttamrao Mangate Also directs: Pulsenext Health LLP, Ramang Construction Private Limited | Director | 09 Nov 2020 | 5 Years 11 Months | Current |
| Sandeep Uttamrao Mangate Also directs: Pulsenext Health LLP | Additional Director | 05 Sep 2025 | 1 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Cisza Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cisza Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cisza Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cisza Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Sandeep Uttamrao Mangate was appointed as Additional Director on 05 Sep 2025.
AGM
Cisza Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Sandeep Uttamrao Mangate was appointed as Additional Director.
Filing
Cisza Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Amol Asaram Dahayalkar was appointed as Director.
Appointed
Rameshwar Uttamrao Mangate was appointed as Director.
Incorporation
09 Nov 2020
Cisza Pharmaceuticals Private Limited was registered on 09 Nov 2020 with Roc Mumbai Ii & aged 5 years 11 months as per MCA records.
Frequently asked questions
Cisza Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 November 2020 (6+ years old) and is registered under CIN U24297MH2020PTC349749.
Cisza Pharmaceuticals has 2 current directors:
- Rameshwar Uttamrao Mangate - Director
- Sandeep Uttamrao Mangate - Additional Director
The latest financial statements of Cisza Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Cisza Pharmaceuticals is U24297MH2020PTC349749. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cisza Pharmaceuticals was incorporated on 09 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Sandeep Uttamrao Mangate was appointed as Additional Director on 05 Sep 2025. Amol Asaram Dahayalkar was appointed as Director on 09 Nov 2020. Rameshwar Uttamrao Mangate was appointed as Director on 09 Nov 2020.
Yes, Cisza Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-04-0059756).
The registered office of Cisza Pharmaceuticals is at Gut No. 151P Plot No. 38 Disha Nisarg, Aurangabad, Maharashtra, India – 431001.
Cisza Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Cisza Pharmaceuticals can be reached at its registered office: Gut No. 151P Plot No. 38 Disha Nisarg, Aurangabad, Maharashtra, India – 431001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages